Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Precancerous Conditions

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Precancerous Conditions in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Precancerous Conditions: Pathological conditions that tend eventually to become malignant.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, H1
Yamamoto, M1
Hashimoto, N1
Miyakoshi, M1
Tamakawa, S1
Yoshie, M1
Tokusashi, Y1
Yokoyama, K1
Yaginuma, Y1
Ogawa, K1
Faurschou, A1
Gniadecki, R1
Calay, D1
Wulf, HC1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Precancerous Conditions

ArticleYear
Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis.
    Cancer research, 2006, Dec-01, Volume: 66, Issue:23

    Topics: Animals; Blotting, Western; Cell Line, Tumor; Chromones; Disease Progression; Enzyme Inhibitors; Gen

2006
TNF-alpha impairs the S-G2/M cell cycle checkpoint and cyclobutane pyrimidine dimer repair in premalignant skin cells: role of the PI3K-Akt pathway.
    The Journal of investigative dermatology, 2008, Volume: 128, Issue:8

    Topics: bcl-Associated Death Protein; Cell Cycle; Cell Line; Cell Proliferation; Cell Survival; Chromones; D

2008